https://pubmed.ncbi.nlm.nih.gov/40263288/?dopt=Abstract
QKI-induced circ_0001766 inhibits colorectal cancer progression and rapamycin resistance by...
Colorectal cancer (CRC) is the third most common cancer and remains a significant challenge due to high rates of drug resistance and limited therapeutic...
colorectal cancer